DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Folprecht G et al.
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma.
Ann Oncol 2006;
17 (03) 450-456
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.